<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this paper is to describe imaging techniques and findings of T2-weighted magnetic resonance imaging (MRI) of <z:hpo ids='HP_0000969'>edema</z:hpo> in <z:e sem="disease" ids="C0878544" disease_type="Disease or Syndrome" abbrv="">myocardial diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>T2-weighted cardiac MRI is acquired by combining acceleration techniques with motion and signal suppression techniques </plain></SENT>
<SENT sid="2" pm="."><plain>The MRI findings should be interpreted based on coronary artery supply, intramural distribution, and comparison with delayed-enhancement MRI </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0878544" disease_type="Disease or Syndrome" abbrv="">myocardial diseases</z:e>, such as <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:mp ids='MP_0001856'>myocarditis</z:mp>, the <z:hpo ids='HP_0000969'>edema</z:hpo> is larger than myocardial <z:hpo ids='HP_0100699'>scarring</z:hpo>, whereas the <z:hpo ids='HP_0000969'>edema</z:hpo> can be smaller than the <z:hpo ids='HP_0100699'>scarring</z:hpo> in some types of nonischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, including <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>T2-weighted MRI of <z:hpo ids='HP_0000969'>edema</z:hpo> identifies myocardial <z:hpo ids='HP_0000969'>edema</z:hpo> associated with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, or intervention in the myocardium and provides information complementary to delayed-enhancement MRI </plain></SENT>
</text></document>